Investors: How to Prepare for the “Next Generation” of Weed Stock IPOs

After Akerna Corp’s (NASDAQ:KERN) merger, there’s reason to believe that weed stock IPOs will be successful.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

The quick returns generated by weed stock IPOs are almost unprecedented in stock market history.

As a case in point, consider Tilray.

After its IPO, Tilray rallied 750% in the span of a few short months. Although it cooled off shortly afterward, the stock’s rise shows how quickly weed stocks can make investors wealthy.

Unfortunately, with growing losses and increasing regulatory scrutiny, established weed stocks aren’t looking like great long-term plays. However, short-term investors may be able to profit off of the hype generated by upcoming IPOs.

Over the past few months, several marijuana related companies have quietly gone public, with others forming through mergers. Many of them have made investors wealthy, despite the generally bearish trends observed in the cannabis sector. In this article, I’ll be exploring how you can get in on the next generation of marijuana stock IPOs before they peak.

What the Akerna merger teaches us

Akerna (NASDAQ:KERN) is a marijuana compliance company that was formed by the merger of MJ Freeway and MTech Acquisition Corp. The company builds software that lets marijuana companies track their supply chain and allows governments to monitor plant shipments for compliance purposes.

As a software company, Akerna is insulated from market factors that may hamper weed producers’ growth, such as changes in fair value of biological assets or declining selling prices. After its IPO, the company briefly shot up 182% before coming back down to earth. It’s still up 35% from its IPO price.

Researching upcoming IPOs

As the Akerna merger teaches us, new weed stock offerings can create many short-term opportunities. Although technically not an IPO, it demonstrates the insatiable appetite investors have for new weed stocks.

While Akerna’s moment seems to be in the past, there are plenty of upcoming offerings to look forward to. If you want to take advantage of them, the key is to research the options available and decide which has the most potential upside.

In terms of production capacity, Breath of Life — which was slated to go public last week but was delayed — looks especially promising. Planning to produce 870,000 kilograms a year, it already has the space in Israeli and Portuguese production facilities to back it up. It plans to offer $150 million worth of shares and use the funds to get production up and running.

Another interesting option is Cannalife. It develops and markets a number of topical cannabis creams and is looking to go public sometime this year. Although its products are facing regulatory hurdles right now, their novel nature means that they could enjoy patent protection and get an “economic moat” that results in higher-than-usual profit margins.

Foolish takeaway

Over the years, marijuana stocks have made many investors wealthy. Historically, the key has been getting in early. While large-cap weed stocks are floundering now, they were superstars while still young. At the moment, there are at least two significant marijuana stock IPOs coming up, either one of which could become the next big thing. Stay tuned.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »